American Medical Association Resolution 503 (2009)

Introduced by:  American Institute of Ultrasound in Medicine

Subject:  Ultrasound Contrast Agents


503. ULTRASOUND CONTRAST AGENTS Introduced by American Institute of Ultrasound in Medicine and American Association of Clinical Endocrinologists

HOUSE ACTION: FOLLOWING SUBSTITUTE RESOLUTION 503 ADOPTED

RESOLVED, that our American Medical Association (AMA) encourage the appropriate medical specialty societies to develop evidence-based guidelines addressing the clinical use of microbubble ultrasound contrast agents, and be it further

RESOLVED, that our AMA encourage sponsors to submit the necessary applications to the Food and Drug Administration in support of additional approved indications for microbubble ultrasound contrast agents.

ICUS Sponsors

ICUS gratefully acknowledges its 2017 sponsors:

dentons-logo2

silver-level

philips-icus-logo

samsung-logo

Toshiba Medical logo resized

siemens-new-original

mindray

Contact ICUS

  • Address: 1900 K Street, N.W.
    Washington, DC 20006-1102, USA
  • Telephone: 202-408-6199

About ICUS

ICUS is the world’s only professional society exclusively devoted to contrast-enhanced ultrasound (CEUS) medical imaging technology.

Learn more...

You are here: Home AMA Resolution